Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity
d) 15 nM BG-ASO and 35 nM control ASO over 100 nM control ASO
Koch Research is your trusted partner in conducting weight loss clinical trials with a team of experts and state-of-the-art technology
Considerations When Choosing a Clinic Licensed dermatologists and qualified medical staff
A joint position paper by the World Heart Federation and World Obesity Federation, European Journal of Preventive Cardiology [accessed 16 October 2025] Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial, JAMA Psychiatry [accessed 16 October 2025] Once-Weekly Semaglutide in Adults with Overweight or Obesity, NEJM [accessed 16 October 2025] Phase 3 Trial of Semaglutide in Metabolic DysfunctionAssociated Steatohepatitis, NEJM [accessed 16 October 2025] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, NEJM [accessed 16 October 2025] The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis, Journal of Clinical Medicine [accessed 16 October 2025] Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled pen, emc [accessed 16 October 2025] Weight loss jab 'could reduce heart attack risk', BBC News [accessed 16 October 2025] Patient Reviews Related Weight Loss Treatments Further Reading on Weight Loss Do Appetite Suppressants Work
However, in a meta-analysis of eight cardiovascular outcome trials, GLP-1ras reduced a composite kidney outcome by 21% [7], although the underlying mechanisms are sparsely elucidated
